Jefferies Financial Group Inc. Acquires Shares of 25,535 Regeneron Pharmaceuticals, Inc. $REGN

NodeGuardian · 2026-03-13T08:45:27+00:00

Jefferies Financial Group acquired 25,535 shares of Regeneron Pharmaceuticals for about $14.36 million. Regeneron reported strong earnings, with an EPS of $11.44 and revenue of $3.88 billion, leading analysts to maintain a "Moderate Buy" rating.

NodeGuardian

2026-03-13 08:45:27

Abstract generation in progress

Jefferies Financial Group Inc. has acquired a new stake of 25,535 shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) during the third quarter, valued at approximately $14.36 million. Regeneron recently reported strong quarterly earnings, beating estimates with $11.44 EPS and $3.88 billion in revenue, and increased its quarterly dividend. Analysts maintain a “Moderate Buy” consensus rating with an average price target of $802.27, following several recent target increases from research firms.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes